Alexander Völkner

Prior to joining qPharmetra in September 2018, Alexander worked as a Senior Scientist at AbbVie, where he was the clinical pharmacology and pharmacometrics lead of multiple Phase I/II studies supporting the development of biologics and small molecules in immunology. During his two and a half years at AbbVie, Alexander was responsible to inform and optimize study design through population modeling and simulation and provided strategic input across multidisciplinary teams to ensure the successful integration of clinical pharmacology aspects into the overall project development. Besides his established expertise in population modeling and model-based drug development, he also authored clinical study reports, Phase I/II protocols, PK/PD reports and supported clinical pharmacology sections of regulatory documents. Alexander obtained his PhD in pharmaceutical sciences from the University of Florida, where he worked in the therapeutic area of infectious diseases and is a pharmacist by training.